1. Home
  2. TRAW vs LMFA Comparison

TRAW vs LMFA Comparison

Compare TRAW & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRAW
  • LMFA
  • Stock Information
  • Founded
  • TRAW 1998
  • LMFA 2008
  • Country
  • TRAW United States
  • LMFA United States
  • Employees
  • TRAW N/A
  • LMFA N/A
  • Industry
  • TRAW
  • LMFA Finance: Consumer Services
  • Sector
  • TRAW
  • LMFA Finance
  • Exchange
  • TRAW NYSE
  • LMFA Nasdaq
  • Market Cap
  • TRAW 8.6M
  • LMFA 8.6M
  • IPO Year
  • TRAW 2013
  • LMFA 2015
  • Fundamental
  • Price
  • TRAW $1.48
  • LMFA $2.66
  • Analyst Decision
  • TRAW
  • LMFA Hold
  • Analyst Count
  • TRAW 0
  • LMFA 1
  • Target Price
  • TRAW N/A
  • LMFA N/A
  • AVG Volume (30 Days)
  • TRAW 3.4M
  • LMFA 104.6K
  • Earning Date
  • TRAW 08-14-2025
  • LMFA 08-13-2025
  • Dividend Yield
  • TRAW N/A
  • LMFA N/A
  • EPS Growth
  • TRAW N/A
  • LMFA N/A
  • EPS
  • TRAW N/A
  • LMFA N/A
  • Revenue
  • TRAW $227,000.00
  • LMFA $8,029,601.00
  • Revenue This Year
  • TRAW $3.81
  • LMFA $0.98
  • Revenue Next Year
  • TRAW $30.43
  • LMFA $4.31
  • P/E Ratio
  • TRAW N/A
  • LMFA N/A
  • Revenue Growth
  • TRAW 0.44
  • LMFA N/A
  • 52 Week Low
  • TRAW $0.97
  • LMFA $1.02
  • 52 Week High
  • TRAW $19.44
  • LMFA $5.35
  • Technical
  • Relative Strength Index (RSI)
  • TRAW 43.63
  • LMFA 69.13
  • Support Level
  • TRAW $1.37
  • LMFA $2.18
  • Resistance Level
  • TRAW $1.49
  • LMFA $2.89
  • Average True Range (ATR)
  • TRAW 0.11
  • LMFA 0.22
  • MACD
  • TRAW -0.03
  • LMFA 0.10
  • Stochastic Oscillator
  • TRAW 12.07
  • LMFA 82.68

About TRAW TRAWS PHARMA INC

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: